Replies to post #52773 on Genta, Inc (fka GNTAQ)

[nutriman24]

I believe the FDA is going to give GNTA the green light after reviewing these results.
“These data confirm substantial activity for tesetaxel as initial chemotherapy for women with advanced, HER2-negative, breast cancer”, said Dr. Loretta M. Itri, Genta’s President, Pharmaceutical Development, and Chief Medical Officer. “Based on aggregate data from our multicenter Phase 2 trials, we will be conferring with FDA to identify potential registration strategies for tesetaxel in breast cancer.”

[BANKERB]

smitter-If FINRA denies the appeal to Reverse Split this month do you think there is a chance that FINRA won't allow them to do anymore reverse splits next year?

thanks
Banker